congenital myasthenic syndrome 16

Summary
Synonym
  • CMS16
  • congenital myasthenic syndrome acetazolamide-responsive
Definition
A congenital myasthenic syndrome that has_material_basis_in heterozygous or homozygous mutation in the SCN4A gene on chromosome 17q23.
Super Class
autosomal recessive disease congenital myasthenic syndrome
External Links
Disease Ontology
DOID:0110682
Mondo Disease Ontology
OMIM
Related Genes
Displaying 1 entry
Gene ID Gene Symbol Description Source
6329 SCN4A sodium voltage-gated channel alpha subunit 4
Displaying 1 entry
Gene ID Gene Symbol Description Source
110880 Scn4a sodium channel, voltage-gated, type IV, alpha
Displaying 1 entry
Gene ID Gene Symbol Description Source
25722 Scn4a sodium voltage-gated channel alpha subunit 4
Displaying 1 entry
Gene ID Gene Symbol Description Source
32619 para paralytic
Displaying all 2 entries
Gene ID Gene Symbol Description Source
564977 scn4ab sodium channel, voltage-gated, type IV, alpha, b
572442 scn4aa sodium channel, voltage-gated, type IV, alpha, a
The Human Phenotype Ontology
Displaying entries 1 - 10 of 32 in total
HPO ID HPO Term
HP:0001324 Muscle weakness
HP:0002878 Respiratory failure
HP:0000597 Ophthalmoparesis
HP:0003403 EMG: decremental response of compound muscle action potential to repetitive nerve stimulation
HP:0002329 Drowsiness
HP:0000496 Abnormality of eye movement
HP:0003388 Easy fatigability
HP:0002091 Restrictive ventilatory defect
HP:0003458 EMG: myopathic abnormalities
HP:0000961 Cyanosis
Displaying 1 entry
Gene ID Gene Symbol Description
375790 AGRN agrin

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024